BCL2 and neoplasm: A peptide designed to specifically block the interaction between the MHV68-encoded homolog of Bcl-2 M11 and BECN1 (therefore, preventing M11-mediated downregulation of autophagy) could be used to both restore the tumor suppressor activity of BECN1 and to limit the reservoir of viral latency [103].